EGFR and gastric cancer: Additionally, it was demonstrated to predict clinical outcome in advanced gastric cancer during combination therapy with Folfiri and cetuximab [16] but tumor metabolism has not been analyzed in terms of single agent treatment with an EGFR mAB.